Comparison of SAR341402 to NovoLog/NovoRapid in Adult Patients With Diabetes Mellitus Also Using Insulin Glargine

Clinical trial NCT03211858 · COMPLETED

Trial details

NCT number: NCT03211858
Sponsor: Sanofi
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Type 1 Diabetes Mellitus-Type 2 Diabetes Mellitus

Start date: 2017-08-02
Primary completion: 2018-07-16
Enrollment: 597

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.